Mental Health & Depression: 87 trials across 10 countries, 3,284 recruiting. 2 Phase 3. 573 papers. August 17 – August 24, 2026.
Doctiplus - We are allways here!
0Likes
Cancer & Oncology: 182 trials across 10 countries, 18,875 recruiting. 3 Phase 3. 2,293 papers. August 17 – August 24, 2026.
0Likes
Diabetes (Type 2): 38 trials across 10 countries, 1,959 recruiting. 2 Phase 3. 372 papers. August 17 – August 24, 2026.
0Likes
Heart Disease & Cardiovascular: 101 trials across 10 countries, 8,792 recruiting. 3 Phase 3. 1,074 papers. August 17 – August 24, 2026.
0Likes
Dementia & Alzheimer’s: 13 trials across 8 countries, 949 recruiting. 0 Phase 3. 1,301 papers. August 17 – August 24, 2026.
0Likes
Mental Health & Depression: 65 new trials, 3,265 recruiting, 1,673 papers published, Aug 10-17, Off Label Use tops 3,697 reports.
0Likes
Cancer & Oncology: 162 new trials, 18,833 recruiting, 4 Phase 3. Off Label Use tops adverse reports at 8602. August 10–17.
0Likes
Diabetes Type 2: 21 new trials, 1,953 recruiting, 1,373 papers published. Off Label Use tops 9,990 reports. August 10–17.
0Likes
Heart Disease & Cardiovascular: 118 new trials, 8,762 recruiting, 2,138 papers published, Fatigue tops adverse reports at 6,730. August 10-17.
0Likes
Dementia & Alzheimer’s: 13 new trials, 945 recruiting, 2 Phase 3. Death tops adverse reports at 629. 319 papers published, August 10–17.